Infectopharm Expands into Poland with New European Sales Hub
German pharmaceutical company Infectopharm is expanding into Poland, marking its fifth European sales and marketing hub. The move strengthens the firm’s presence in a key market with a large population and growing healthcare sector. Leading the new office will be Beata Treszczynska, an industry veteran with experience at major firms like Robi and Indivior.
Infectopharm has chosen Poland as its latest European base due to its strategic advantages. The country’s central location, EU membership, and increasing healthcare investment make it an attractive market. The company already operates in Austria, Italy, France, and the UK, employing over 450 people and generating €300 million in revenue in 2024.
The new Polish office will be headed by Beata Treszczynska, who brings years of pharmaceutical leadership. Her appointment reflects Infectopharm’s focus on building a strong local team. The company plans to introduce its first products in Poland in 2026, though no exact date has been set. International expansion remains a major growth driver for Infectopharm. The firm currently distributes its products in over 30 countries, with overseas operations contributing significantly to its revenue.
The Polish expansion adds to Infectopharm’s growing European network. With Treszczynska at the helm, the company aims to establish a strong foothold in the market. The launch of its first products in 2026 will mark the next step in its regional growth strategy.
Read also:
- Federal Funding Supports Increase in Family Medicine Residency Program, Focusing on Rural Health Developments
- Potential Role of DHA in Shielding the Brain from Saturated Fats?
- Alternative Gentle Retinoid: Exploring Bakuchiol Salicylate for Sensitive Skin
- Hanoi initiates a trial program for rabies control, along with efforts to facilitate the transition from the dog and cat meat trade industry.
